Evidence map›Paper›PMID 38187382›Full record

ArticleFrontiers in immunology2023

Recombinant antigen P29 of

Jihui Yang, Yinqi Zhao, Yong Fu, Yongxue Lv, Yazhou Zhu, Mingxing Zhu, Jiaqing Zhao, Yana Wang, Changyou Wu, Wei Zhao

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Effects of recombinantFrontiers in cellular and infection microbiology · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Jihui Yang *Center of Scientific Technology of Ningxia Medical University, Yinchuan, China.
Yinqi Zhao *Center of Scientific Technology of Ningxia Medical University, Yinchuan, China.
Yong Fu *Qinghai Academy of Animal Sciences and Veterinary Medicine, Qinghai University, Xining, China.
Yongxue LvNingxia Key Laboratory of Prevention and Treatment of Common Infectious Diseases of Ningxia Medical University, Yinchuan, China.
Yazhou ZhuNingxia Key Laboratory of Prevention and Treatment of Common Infectious Diseases of Ningxia Medical University, Yinchuan, China.
Mingxing ZhuCenter of Scientific Technology of Ningxia Medical University, Yinchuan, China.
Jiaqing ZhaoCenter of Scientific Technology of Ningxia Medical University, Yinchuan, China.
Yana WangNingxia Key Laboratory of Prevention and Treatment of Common Infectious Diseases of Ningxia Medical University, Yinchuan, China.
Changyou WuInstitute of Immunology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.
Wei ZhaoCenter of Scientific Technology of Ningxia Medical University, Yinchuan, China.
Ningxia Medical University · CNQinghai University · CNSun Yat-sen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

EchinococcosisEchinococcus granulosusVaccinesAnimalsCD8-Positive T-LymphocytesCytokinesEnzyme-Linked Immunospot AssayHumansImmunityInterleukin-17Leukocytes, MononuclearMiceMyeloblastinSheepTh17 CellsCytokinesInterleukin-17MyeloblastinVaccinescellular immunityEchinococcus granulosusrecombinant antigen P29sheepTc1Th1Th17

Identifiers

PMID38187382
PMCPMC10768560
OpenAlexW4389565400

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.